Arlington Partners LLC Biogen Inc. Transaction History

Arlington Partners LLC

$241 Million
Q3 2024

A detailed history of Arlington Partners LLC transactions in Biogen Inc. stock. As of the latest transaction made, Arlington Partners LLC holds 19,214 shares of BIIB stock, worth $3.03 Million. This represents 1.55% of its overall portfolio holdings.

Number of Shares

19,214

Previous 14,312 34.25%

Holding current value

$3.03 Million

Previous $3.32 Million 12.27%

% of portfolio

1.55%

Previous 1.76%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$189.07 - $236.8 $926,821 - $1.16 Million	4,902 Added 34.25%	19,214 $3.72 Million
Q2 2024 Aug 01, 2024	BUY	$190.52 - $236.72 $347,317 - $431,540	1,823 Added 14.6%	14,312 $3.32 Million
Q1 2024 Apr 16, 2024	BUY	$212.02 - $267.71 $176,612 - $223,002	833 Added 7.15%	12,489 $2.69 Million
Q4 2023 Jan 24, 2024	BUY	$222.59 - $267.94 $2.59 Million - $3.12 Million	11,656 New	11,656 $3.02 Million
Q2 2023 Jul 26, 2023	SELL	$275.25 - $318.06 $13,762 - $15,903	-50 Reduced 0.99%	5,025 $1.43 Million
Q1 2023 Apr 26, 2023	SELL	$256.56 - $292.34 $52,338 - $59,637	-204 Reduced 3.86%	5,075 $1.41 Million
Q4 2022 Jan 19, 2023	SELL	$252.44 - $306.72 $342,308 - $415,912	-1,356 Reduced 20.44%	5,279 $1.46 Million
Q3 2022 Oct 28, 2022	BUY	$194.69 - $268.46 $22,584 - $31,141	116 Added 1.78%	6,635 $1.77 Million
Q2 2022 Jul 25, 2022	SELL	$187.54 - $223.02 $184,726 - $219,674	-985 Reduced 13.13%	6,519 $1.33 Million
Q1 2022 Apr 14, 2022	SELL	$193.77 - $244.14 $287,942 - $362,792	-1,486 Reduced 16.53%	7,504 $1.58 Million
Q4 2021 Jan 18, 2022	BUY	$223.92 - $287.77 $51,949 - $66,762	232 Added 2.65%	8,990 $2.16 Million
Q3 2021 Oct 15, 2021	BUY	$282.99 - $369.05 $138,099 - $180,096	488 Added 5.9%	8,758 $2.48 Million
Q2 2021 Jul 07, 2021	SELL	$259.0 - $414.71 $11,137 - $17,832	-43 Reduced 0.52%	8,270 $2.86 Million
Q1 2021 Apr 19, 2021	BUY	$242.95 - $284.63 $182,941 - $214,326	753 Added 9.96%	8,313 $2.33 Million
Q4 2020 Jan 13, 2021	BUY	$236.26 - $355.63 $3,071 - $4,623	13 Added 0.17%	7,560 $1.85 Million
Q2 2020 Jul 13, 2020	BUY	$258.66 - $342.55 $162,955 - $215,806	630 Added 9.11%	7,547 $2.02 Million
Q1 2020 Apr 13, 2020	BUY	$268.85 - $341.04 $1.47 Million - $1.86 Million	5,452 Added 372.15%	6,917 $2.19 Million
Q4 2019 Jan 16, 2020	BUY	$220.06 - $304.07 $72,619 - $100,343	330 Added 29.07%	1,465 $435,000
Q3 2019 Oct 18, 2019	SELL	$217.44 - $243.88 $1.52 Million - $1.71 Million	-7,011 Reduced 86.07%	1,135 $264,000
Q2 2019 Jul 10, 2019	BUY	$219.29 - $241.72 $1.67 Million - $1.84 Million	7,631 Added 1481.75%	8,146 $1.91 Million
Q1 2019 Apr 05, 2019	SELL	$216.71 - $338.96 $410,665 - $642,329	-1,895 Reduced 78.63%	515 $122,000
Q4 2018 Jan 10, 2019	BUY	$278.5 - $352.75 $33,420 - $42,330	120 Added 5.24%	2,410 $725,000
Q3 2018 Oct 23, 2018	BUY	$293.51 - $383.83 $7,337 - $9,595	25 Added 1.1%	2,290 $809,000
Q1 2018 May 07, 2018	BUY	$260.13 - $367.91 $58,529 - $82,779	225 Added 11.03%	2,265 $620,000
Q4 2017 Jan 29, 2018	BUY	$307.64 - $344.58 $627,585 - $702,943	2,040	2,040 $650,000

Others Institutions Holding BIIB

# of Institutions

1,036

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arlington Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arlington Partners LLC with notifications on news.

Account

Arlington Partners LLC Biogen Inc. Transaction History